Clinical trial
Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects…
NCT00330785 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00330785 |
|---|---|
| Title | Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia |
| Official title | An International, Multicentre, Open Label Study To Assess The Effectiveness Of Amlodipine -Atorvastatin Combination In Subjects With Hypertension and Dyslipidaemia. (The JEWEL Study) |
| Acronym | JEWEL I |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension, Dyslipidemia |
| Intervention type | Drug |
| Interventions | Amlodipine/Atorvastatin |
| Enrollment | 1,250 |
| Start date | Oct 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | May 29, 2006 |
| Last update posted | Jan 27, 2021 |
| Countries | Canada, United Kingdom |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: